EN DE

Astera Labs, Inc. (ALAB) Fair Value & Analysis

Technology · US · Market cap $49.0B · ISIN US04626A1034

AL Astera Labs, Inc. logo Astera Labs, Inc. ALAB · US
Price$289.47
Fair Value$21.47
Upside-92.6%
Quality73/100

Structural break: The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.

Watch Astera Labs, Inc. for free, get notified when fair value or trend changes. Watch for free

Strengths

Healthy Growth (revenue 3y +120.2 %/yr)
Highly profitable · 30.7% net margin
generates free cash flow
Wide moat 82/100

Risks

!Trades 1248% ABOVE our fair value of $21.47
!Mixed vs. peers (6/11)
!Evidence only low, so the estimate is less certain
Healthy Growth (revenue 3y +120.2 %/yr)
Highly profitable · 30.7% net margin
generates free cash flow
Mixed vs. peers (6/11)
Wide moat 82/100
Evidence: Low Range $16.10 – $26.84 Share as image

Fair value as of: Aug 27, 2026

From 24 valuation models · updated 3 days ago

Fair value updated Aug 27, 2026, revised from $21.73 to $21.47 (−1.2%) since Aug 13, 2026. Share price +15.9% over the past month.

A solid business, but trading 1,248% above our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Track Astera Labs, Inc. and get told automatically when its fair value or trend turns, plus fair value for all 35,000+ stocks. 14 days of Pro free, no card. Track it free

What matters now

  • A high-quality business (quality 73/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case ($26.84). The favourable scenario is already priced in.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (2 years)

$483.02 $36.37 Fair Value $21.47 Mar 2024 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 27, 2026.

How to read this chart

29‑month range $36.37 – $483.02 · fair‑value band $16.10 – $26.84 · the $289.47 price screens above the $21.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 27, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Astera Labs, Inc. (ALAB) currently trades at $289.47, while our model-based Fair Value estimate is $21.47, implying the stock looks roughly 92.6% overvalued today. The Quality Score stands at 73/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Astera Labs, Inc. generated revenue of $1.0B at a net margin of 26.7%. Revenue grew 93.4% year over year. It earns a return on equity of 21.1%. The balance sheet holds a net cash position of $132M. Fundamentals as of Aug 27, 2026

Our scenario range runs from $16.10 (bear case) to $26.84 (bull case); at $289.47, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 22% below its 52-week high and 241% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at -59% fair-value upside, at -93%, ALAB screens richer than that median.

Fair Value models

This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly 0.96 USD per share, which is 4.5 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Note: the current price implies far more future growth than the conservative anchors of our models allow (base growth is deliberately capped, we do not regard such extreme rates as sustainable). Our models are not designed for expectations this high; that is why the individual models scatter extremely ($5.27 to $63.85). Read the values as a conservative anchor, not as a price target.
Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
EPV best evidence $9.53 $10.96 $12.21 70
FCF DCF $28.30 $43.98 $93.90 68
Growth DCF $26.68 $52.00 $93.49 67
All 24 models by family
DCF Models
FCF DCF $28.30 $43.98 $93.90 68
Owner Earnings $18.02 $39.76 $85.42 63
5Y Revenue Exit $15.81 $24.67 $43.04 63
5Y EBITDA Exit $19.04 $31.20 $54.99 65
5Y P/E Exit $28.48 $62.68 $109.32 60
10Y Revenue Exit $19.29 $36.57 $46.11 60
10Y EBITDA Exit $22.06 $43.53 $79.54 58
10Y P/E Exit $28.95 $63.85 $121.33 54
Earnings-Based
Graham-Dodd $8.59 $59.90 $84.06 59
Lynch FV $30.95 $44.21 $57.47 57
PEG = 1.0 $30.95 $44.21 $57.47 53
EPV best evidence $9.53 $10.96 $12.21 70
Multiples
P/E Multiple $26.53 $35.37 $44.21 63
P/S Multiple $16.10 $21.47 $26.84 58
P/B Multiple $16.10 $21.47 $26.84 55
EV/EBIT $18.96 $24.96 $30.96 63
EV/EBITDA $14.99 $19.67 $24.34 64
EV/Revenue $10.06 $13.96 $17.86 51
Asset-Based
NCAV (Graham) $3.93 $5.27 $7.86 51
Growth DCF
Growth DCF $26.68 $52.00 $93.49 67
Rev-Margin DCF $17.23 $28.11 $51.03 62
Economic Profit
Residual Income $8.40 $11.17 $36.17 54
ROIC Compounder $11.61 $15.99 $20.05 66
Growth Earnings
Growth-Adj P/E $44.69 $63.84 $82.99 63

Widest divergence: Growth Earnings ($63.84) versus Asset-Based ($5.27). Highest evidence: EPV (70).

Notify me when ALAB reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 142.6
P/S ratio 36.7 P/E × margin
EPS (TTM) $2.03 price ÷ EPS = P/E 142.6
Net margin 25.7% FY2025
Return on equity 25.8% TTM
Return on assets (EBIT) -10.8% avg 4y
More key figures
Profitability
Operating margin 22.7% TTM
Growth
Revenue (TTM) $1.2B TTM
Revenue growth (YoY) +105% 3y avg +120%
EPS growth (YoY) +186%
Balance sheet & cash flow
Free cash flow $282M FY2025
Net cash $132M FY2025

Figures from reported company fundamentals · as of Aug 27, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 73/100

Of which business quality 73 · Market factors (momentum, volatility) 53

Profitability 71
Margins and returns on capital today
Quality Growth 89
Are margins and returns improving?
Cashflow 88
Earnings quality: real cash, not paper profit
Fin. Strength 87
Balance sheet, leverage, solvency risk
Investment 43
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 77
Price trend over the last 3–12 months (market factor)
52W Momentum 74
Distance to the 52-week high (market factor)
Net Issuance 42
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure in Taiwan and the United States. It offers an intelligent connectivity platform, comprised of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS.

Full company description

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure in Taiwan and the United States. It offers an intelligent connectivity platform, comprised of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS. The company provides COSMOS software suite, a connectivity system management and optimization software that enables management and optimization of resources for large fleets at cloud-scale via link, fleet, and RAS management capabilities. In addition, it offers PCIe/CXL smart DSP retimers and cable modules; ethernet smart cable modules for cloud and AI infrastructure; CXL memory connectivity controllers; and smart fabric switches. The company serves hyperscalers and system original equipment manufacturers. Astera Labs, Inc. was incorporated in 2017 and is based in San Jose, California.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2025 · reported fiscal years

Astera Labs, Inc. reported revenue of $853M in FY2025 versus $79.9M in FY2022, a compound +120.2%/yr. Reported net income was $219M in FY2025.

Growth Quality 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$853M
Latest YoY
+115.1%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+120.2%
Value creation/yr We only publish this rate when it is defensible. Reason: no profitable base year
not computed
Revenue +120.2%/yr
FY22 $79.9M
FY23 $116M
FY24 $396M
FY25 $853M
Net income
FY22 −$58.3M
FY23 −$26.3M
FY24 −$83.4M
FY25 $219M

ALAB screens 1,248% overvalued. Compare with NVIDIA Corporation →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Astera Labs, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/ALAB

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Semiconductors · 325 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 73 · Top 25%
Fair Value upside −93% · Bottom 25%
Return on equity (TTM) 26% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 31% · Top 25%
Operating margin (TTM) 23% · Top 25%
Revenue growth 105% · Top 25%

Valuation Multiples vs Semiconductors median · lower = cheaper

P/E (TTM) 142.6× · Pricier than 75% of peers
P/B 35.96× · Pricier than 75% of peers
P/S (TTM) 40.80× · Pricier than 75% of peers
P/FCF 174.0× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 0
FUTURE100 · sector 64
PAST100 · sector 25
HEALTH0 · sector 96
DIVIDEND0 · sector 18

VALUE 0: the price sits above our fair-value range.

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Semiconductors stocks, each showing price versus our Fair Value estimate (as of Aug 27, 2026).

Stock Price Fair Value vs Fair Value
NVIDIA Corporation NVDA $227.98 $98.98 -57%
Taiwan Semiconductor Manufacturing Company TSM $427.30 $296.10 -31%
Broadcom Inc AVGO $371.54 $118.27 -68%
SK hynix Inc 000660 1,730,000 KRW 1,481,291 KRW -14%
Micron Technology, Inc MU $932.86 $148.38 -84%
Advanced Micro Devices, Inc AMD $476.67 $55.02 -88%
Intel Corporation INTC $92.09 $35.41 -62%
Texas Instruments Incorporated TXN $266.54 $78.54 -71%
QUALCOMM Incorporated QCOM $164.78 $147.20 -11%
MediaTek Inc 2454 3,845 TWD 1,559 TWD -59%

Compare Astera Labs, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Astera Labs, Inc. (ALAB) overvalued or undervalued?
As of Aug 27, 2026, our model estimates a fair value of $21.47 versus a price of $289.47, about −93% (overvalued).
What is the fair value of ALAB?
Our model-based fair value for Astera Labs, Inc. is $21.47 (as of Aug 27, 2026), built from audited fundamentals. The current price: $289.47.
What is the quality score of ALAB?
Astera Labs, Inc. has a Quality Score of 73/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Astera Labs, Inc. (ALAB)?
Astera Labs, Inc. reported trailing-twelve-month revenue of about $1.0B (latest available figure, as of Aug 27, 2026).
What is the net profit margin of ALAB?
The net profit margin of Astera Labs, Inc. is about 26.7%, meaning it keeps roughly 26.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free · no account needed

Watch Astera Labs, Inc. in the live analysis

One click puts Astera Labs, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.